학술논문
Evaluation of prospective real-time quantitative PCR monitoring for minimal residual disease to predict relapse and direct molecularly targeted therapy with arsenic trioxide in acute promyelocytic leukaemia: analysis of 407 patients, including results of the MRC AML1 5 trial: 162
Document Type
Academic Journal
Author
Source
British Journal of Haematology. Apr 01, 2008 141 Suppl 1:59-59
Subject
Language
English
ISSN
0007-1048